Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C vi…

Background & Aims: Since introduction of all-oral interferon-free treatment-regimens for hepatitis C virus infection (HCV), former "difficult to treat" patient-groups, like end-stage renal disease (ESRD)-patients or patients after renal transplant (NTx) are focused on recently, as treatment of those represented an area of unmet therapeutically need. As real-life data of sofosbuvir-based all-oral treatment-regimens is scarce, we investigated on-treatment viral response (otVR) and clinical profiles in ESRD- and NTx-patients. Patients & Methods: Fifteen patients with chronic HCV-infection (2 GT1; 2 GT1a, 7 GT1b; 1…